These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17504277)
21. Thyrotoxic periodic paralysis amongst the ethnic Asians living in the west--an important entity to consider in the hospital setting. Sinharay R QJM; 2009 May; 102(5):361-2. PubMed ID: 19252198 [No Abstract] [Full Text] [Related]
22. Thyrotoxicosis presenting as hypokalaemic paralysis and hyperlactataemia in an oriental man. Al-Jubouri MA; Inkster GD; Nee PA; Andrews FJ Ann Clin Biochem; 2006 Jul; 43(Pt 4):323-5. PubMed ID: 16824287 [TBL] [Abstract][Full Text] [Related]
23. Exercise test in the inter-attack period of thyrotoxic periodic paralysis: a useful diagnostic tool. Tsai MH; Chang WN; Lu CH; Chuang YC; Chen SD; Lee LH; Lin TK; Huang CR Acta Neurol Taiwan; 2006 Dec; 15(4):259-63. PubMed ID: 17214090 [TBL] [Abstract][Full Text] [Related]
24. [Hypokalemic thyrotoxic periodic paralysis (HTPP). Rare differential diagnosis in case of acute tetraparesis in Europe]. Gaul C; Leonhardt G; Spens A; Schneyer U; Zierz S Med Klin (Munich); 2005 Sep; 100(9):583-6. PubMed ID: 16170648 [TBL] [Abstract][Full Text] [Related]
25. Mutation screening in Chinese hypokalemic periodic paralysis patients. Wang W; Jiang L; Ye L; Zhu N; Su T; Guan L; Li X; Ning G Mol Genet Metab; 2006 Apr; 87(4):359-63. PubMed ID: 16386935 [TBL] [Abstract][Full Text] [Related]
26. Muscle membrane excitability after exercise in thyrotoxic periodic paralysis and thyrotoxicosis without periodic paralysis. Arimura K; Arimura Y; Ng AR; Sakoda S; Higuchi I Muscle Nerve; 2007 Dec; 36(6):784-8. PubMed ID: 17722048 [TBL] [Abstract][Full Text] [Related]
27. [Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis]. Shishiba Y Nihon Rinsho; 2006 Dec; 64(12):2339-47. PubMed ID: 17154102 [TBL] [Abstract][Full Text] [Related]
29. Thyrotoxic periodic paralysis in a Polynesian male following highly active antiretroviral therapy for HIV infection. Brown JD; Kangwanprasert M; Tice A; Melish J Hawaii Med J; 2007 Mar; 66(3):60, 62-3. PubMed ID: 17472043 [TBL] [Abstract][Full Text] [Related]
30. Hypokalaemic periodic paralysis in a thyrotoxic Polynesian. Carroll DG Postgrad Med J; 1994 Jan; 70(819):39-40. PubMed ID: 8140018 [TBL] [Abstract][Full Text] [Related]
31. Thyrotoxic Periodic Paralysis. Haider M; Khan Chachar AZ; Munir A J Ayub Med Coll Abbottabad; 2019; 31(4):619-621. PubMed ID: 31933322 [TBL] [Abstract][Full Text] [Related]
32. A 29-year-old Bodybuilder with Liothyronine-induced Thyrotoxic Hypokalaemic Periodic Paralysis. van Bokhorst QNE; Krul-Poel YHM; Smit DL; de Ronde W Eur J Case Rep Intern Med; 2021; 8(3):002362. PubMed ID: 33869098 [TBL] [Abstract][Full Text] [Related]
33. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. Sundborn G; Metcalf P; Scragg R; Schaaf D; Dyall L; Gentles D; Black P; Jackson R N Z Med J; 2007 Jun; 120(1257):U2607. PubMed ID: 17632597 [TBL] [Abstract][Full Text] [Related]
34. Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis. Vendrame F; Verrienti A; Parlapiano C; Filetti S; Dotta F; Morano S Ann Clin Biochem; 2008 Mar; 45(Pt 2):218-20. PubMed ID: 18325191 [TBL] [Abstract][Full Text] [Related]